Heart Attack (MI): STEMI Reperfusion, Serial Troponin & Atypical Ischemic Symptoms

Clinicians use myocardial infarction when ischemia is sufficiently severe and prolonged to kill cardiomyocytes, releasing measurable biomarkers of necrosis. Supply-demand mismatch can contribute, but most emergency heart attacks arise when an atherosclerotic plaque ulcerates, platelets aggregate, and thrombus acutely narrows or occludes an epicardial coronary artery. Collateral flow, plaque burden, oxygen demand and autonomic tone determine how much muscle dies per minute. The National Heart, Lung, and Blood Institute frames MI as sudden loss of blood flow that must be restored quickly to limit scar and pump dysfunction.

The troponin rise defines infarction size and timing in contemporary care, while the ECG distinguishes STEMI—where ST-segment elevation or posterior or lateral equivalents should trigger emergent reperfusion planning—from NSTEMI, where nondiagnostic ST changes or normal baseline traces still permit small or patchy infarction. Understanding that spectrum keeps nurses aligned with catheter lab activation, antithrombotic safety and step-down monitoring intensity.

Type 1 MI dominates acute ward presentations (spontaneous plaque event); supply-demand type 2 MI also elevates troponin without plaque thrombosis and needs different correction of triggers. Nurses should know which pathway the team documents because monitoring intensity, mobilisation, anticoagulation duration and discharge teaching diverge.

↔On a small screen, swipe or scroll sideways to see the full table.

Classic heart attack pain is substernal pressure lasting more than 20 minutes, radiating to jaw, shoulder or arms, often paired with dyspnea and vomiting. Women, older adults and people with diabetes may report dyspnea, indigestion, fatigue, or syncope without “crushing” language—NHLBI and AHA materials highlight atypical patterns that delay care.

Lateral or inferior territories may masquerade as epigastric discomfort; posterior infarctions can hide on a standard 12-lead until ST depression in precordial leads prompts additional views per pathway. Dyspnea from reduced compliance, new mitral regurgitation murmur, or sudden anxiety may be the only clue.

Accelerated atherosclerosis from smoking, hypertension, dyslipidaemia, diabetes, chronic kidney disease and family history underlies most plaque ruptures. Cocaine, severe anaemia, tachyarrhythmia or hypertensive emergency can precipitate supply-demand MI without thrombus. Coronary spasm, spontaneous coronary dissection and embolism are less common but important in pregnancy, younger women and selected cohorts.

12-lead ECG remains the fastest discriminatory step—obtain within minutes of arrival, repeat with symptoms, and compare to prior tracings when available. High-sensitivity troponin detects smaller infarcts: serial sampling follows assay-specific delta rules and institutional accelerated chest-pain pathways. Echocardiography supports wall-motion assessment when ECG is nondiagnostic or shock supervenes; chest X-ray helps pulmonary oedema or alternate diagnoses.

During anticoagulation phases, monitor haemoglobin, platelets and renal function; lactate assists when perfusion is uncertain. Document times—symptom onset, first ECG, first medical contact, drug administration—to align with STEMI quality metrics.

↔On a small screen, swipe or scroll sideways to see the full table.

STEMI: emergent primary PCI is standard when available within guideline time windows; packaged care includes urgent aspirin, P2Y12 loading (often ticagrelor or alternate per protocol), anticoagulation and vigilance for bleeding. When PCI cannot occur promptly, fibrinolysis remains appropriate for eligible patients without contraindications, followed by transfer for angiography per network rules.

NSTEMI: combined antithrombotic strategies and timing of angiography depend on thrombotic and bleeding risk scores; serial troponin, rhythm monitoring and repeat ECG detect escalation. High-intensity statins such as atorvastatin anchor secondary prevention alongside beta-blockade and renin–angiotensin modulation when LV dysfunction appears.

Relief of ischemic pain uses nitroglycerin with blood pressure safeguards; opioids may be required when pain persists despite therapy—document respiratory status. Oxygen is not routine for normoxic patients; titrate to saturations per local guidance.

1. Suspect ACS from symptoms or risk profile → attach monitor, obtain 12-lead ECG per protocol, draw initial labs per order.
2. STEMI criteria met → activate reperfusion pathway, prepare antiplatelet and anticoagulant orders, two IV accesses, keep NPO if cath imminent, mark groin/radial time checks.
3. NSTEMI pathway → timed serial troponin with reassessment; escalate for recurrent pain, arrhythmia, or dynamic ST shifts.
4. Post-reperfusion → monitor access site, distal pulses, recurrent chest pain, ECG for ST re-elevation, urine output, and neurologic deficits suggesting embolism.
5. Disposition → cardiac rehabilitation referral, medication reconciliation, high-intensity statin and antiplatelet education, warning symptoms, and clear follow-up within clinic cadence.

• Pair every nitrate dose with pre/post blood pressure and symptom documentation; screen for phosphodiesterase inhibitor exposure.
• Never crush dual pathways: arterial sheath lines, femoral closure devices and simultaneous heparin infusions demand line labelling and hourly site inspection early after PCI.
• Reperfusion arrhythmias—VF, VT, profound bradycardia—may appear with reperfusion; pads stay available, electrolytes checked.
• β-blockers and ACE inhibitors are uptitrated only when hemodynamically appropriate; hypotension or acute lung congestion changes the sequence.
• Psychological distress is common; brief validated screening during follow-up improves adherence but should not replace psychiatry referral when self-harm ideation emerges.

• Cardiogenic shock, acute pulmonary oedema, free wall or septal rupture, papillary muscle dysfunction causing flash pulmonary oedema.
• Pericarditis post-transmural infarction (Dressler syndrome less common with early reperfusion).
• Left ventricular thrombus and embolic stroke—especially with apical akinesis.
• Stent thrombosis presenting as recurrent ST elevation—time-sensitive cardiology emergency.
• Heart failure from extensive scar or ischemic stunning.

Secondary prevention

Combination antiplatelet duration is individualised for stent type, bleeding, and future procedures. Intensive lipid lowering, blood pressure control, glucose optimisation, smoking cessation and cardiac rehabilitation reduce recurrent MI. NICE quality standard QS99 packages post-MI risk factor targets for systems to audit.

Prognosis

Early successful reperfusion and preserved ejection fraction predict favourable outcomes; anterior MIs, delayed care, CKD and prior heart failure worsen prognosis. Transparent conversations about red-flag symptoms after discharge save lives.

Handover anchors

State infarct territory if known, last pain score, last troponin trend, anticoagulant infusions running, sheath status, and net fluid balance—then vitals. The next nurse should not infer catheter lab events from equipment clutter alone.

Communication pitfalls

Patients may normalise symptoms as “indigestion.” Use teach-back on new aspirin, P2Y12 timing, bleeding precautions, and when to bypass primary care for emergency services.

• Rhythm, ST-segment auto-alerts (if telemetry), blood pressure trends, respiratory rate, SpO₂ on appropriate oxygen.
• Access site checks, distal pulses or perfusion per institutional protocol, occult blood in stool when dual antiplatelet therapy starts.
• Rhythm readiness: external pacing pads or defibrillator availability; know defibrillator escalation pathways.
• Urine output and renal chemistry before contrast exposure; contrast-associated AKI precautions per protocol.

Deterioration cues also include refractory vomiting, grey skin perfusion, rising bedside lactate, or a quietly agitated patient refusing to lie flat—pair subjective unease with objective trends.

Nursing-priority lens (NCSBN Clinical Judgment Measurement Model): recognise cues → analyse cues → prioritise hypotheses → generate solutions → take safe action → evaluate outcomes. These NCLEX-style clinical judgment practice items use Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and cloze drops around STEMI activation, troponin surveillance, nitrate safety, sheath-site bleeding and post-PCI arrhythmias—mirroring the Clinical Judgment Measurement Model emphasis on time-sensitive cardiac care.